Cite
HARVARD Citation
Schöffski, P. et al. (2017). Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours. European journal of cancer. pp. 296-304. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schöffski, P. et al. (2017). Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours. European journal of cancer. pp. 296-304. [Online].